BLIS M18
Also known as: Streptococcus Salivarius M18, Dental Probiotic
BLIS Technologies' dental-targeted probiotic, produces bacteriocins active against Streptococcus mutans and Porphyromonas gingivalis, two common oral bacteria.
- Clinical dose
- 1 billion CFU/day lozenge, the dose used in published pediatric dental trials
- Typical label dose
- 1 billion CFU/day
- Category
- General Health
- Oral Health
- Dental Health
- Immunity
- Antimicrobial
What it is & how it works
Bacteriocin production targets cariogenic and periodontal pathogens; reduces dental biofilm formation; supports salivary IgA; competes for adhesion sites.
Dosage
The clinically studied dose is 1 billion CFU/day lozenge, the dose used in published pediatric dental trials.On labels you'll typically see 1 billion CFU/day.
What the research shows
Dental and oral-microbiome formulas use BLIS M18 for its published dental-plaque data, distinct from K12 in targeting dental rather than throat bacteria.
Studies & citations
Formulas it appears in
- Immune Formula
Immune Formula
Categories
BLIS M18 FAQ
What is BLIS M18?
BLIS Technologies' dental-targeted probiotic, produces bacteriocins active against Streptococcus mutans and Porphyromonas gingivalis, two common oral bacteria.
How much BLIS M18 should I take per day?
The clinically studied dose is 1 billion CFU/day lozenge, the dose used in published pediatric dental trials.
What does BLIS M18 do?
Dental and oral-microbiome formulas use BLIS M18 for its published dental-plaque data, distinct from K12 in targeting dental rather than throat bacteria.
What is BLIS M18 found in?
Immune Formula
Related General Health ingredients
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Educational information only, not medical advice, doses reflect published research. Check with a healthcare professional before starting any supplement.